Efficacy and Safety of Sotalol in Children With Arrhythmia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT03895411

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03895411
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03895411. Randomized; quadruple masking; primary purpose treatment. Start 2019-08 (anticipated); primary completion 2020-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Sotalol in Children With Arrhythmia
Condition
Arrhythmia
Intervention (Drug)
sotalol
Intervention (Drug)
Propafenone
Intervention (Drug)
betaloc
Lead sponsor
Shengjing Hospital (class: other)

Record details

Record id
cardio:ct-nct03895411
Content hash
a15f16ae6812cf3e6e312f1e6714aa10e7449d11a0ed03e7a7fa6cdf1a5d7a1a